The most important question in healthcare AI right now isn’t what the technology can do. It’s whether medicine can keep up with it.
Because the gap is already here. In Oxford, an AI can generate a contrast-enhanced cardiac MRI with no contrast injection at all — safer, faster, cheaper. It’s been working for years. And it still hasn’t reached the community hospital down the road.
This week, Dr. Harvey Castro hosts — with Ed Marx and Dr. Isha Mannering — a conversation with Dr. Yeshe Kway, one of the Oxford scientists who actually builds this technology. He knows exactly why the model that dazzles in a paper doesn’t survive contact with a real hospital, a different patient population, or a payer who’s never heard of it.
How AI-read imaging is shifting medicine from reactive to proactive — and the hard question of who actually gets access.
Why breakthrough imaging AI keeps getting stranded “one mile short of the patient” — the economics, culture, and workflow of adoption.
What it means when AI can predict disease from a routine scan — and the ethics (and risks, like employer discrimination) that come with knowing.
“Medicine doubles its knowledge every 72 days. In the 1950s, it took 50 years”
-Dr. Harvey Castro
[00:00] Cold open — can medicine keep up?
[00:40] Meet the panel + Yeshe’s path: Germany → Singapore → Oxford
[02:10] What can AI actually see inside your whole body?
[04:10] Reactive medicine is dying — what replaces it?
[06:00] It works — so why can’t your hospital use it?
[08:00] Should we tell a child they’ll get sick?
[09:50] Could your employer use AI against you?
[11:40] Is the doctor who won’t use AI already behind?
[13:00] Is AI poisoning medical knowledge?
[14:20] Closing: human + AI
Dr. Junaid Kalia, Neurocritical Care Specialist, Founder of Savelife.AI™
Dr. Harvey Castro, ER Physician, #DrGPT™
Edward Marx, CEO, Advisor

Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.